ferric ferrocyanide has been researched along with Alzheimer Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, Q; Liu, S; Pu, Y; Song, X; Sun, R; Wei, W; Yin, L; Zhang, J | 1 |
| Busquets, MA; Caballero, AB; Espargaró, A; Estelrich, J; Gamez, P; Grapsi, E; Juárez-Jiménez, J; Kowalczyk, J; Sabate, R | 1 |
| Diao, XW; Fa, HB; Li, S; Yin, W; Zhang, D; Zhou, JT | 1 |
3 other study(ies) available for ferric ferrocyanide and Alzheimer Disease
| Article | Year |
|---|---|
Peptide-Functionalized Prussian Blue Nanomaterial for Antioxidant Stress and NIR Photothermal Therapy against Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Mice; Nanostructures; Photothermal Therapy; Reactive Oxygen Species | 2023 |
Dual Effect of Prussian Blue Nanoparticles on Aβ40 Aggregation: β-Sheet Fibril Reduction and Copper Dyshomeostasis Regulation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Copper; Ferrocyanides; Humans; Nanoparticles; Protein Conformation, beta-Strand | 2021 |
The detection of β-amyloid plaques in an Alzheimer's disease rat model with DDNP-SPIO.
Topics: 2-Naphthylamine; Acrylonitrile; Alzheimer Disease; Animals; Case-Control Studies; Coloring Agents; Congo Red; Contrast Media; Disease Models, Animal; Ferrocyanides; Hippocampus; Magnetic Resonance Imaging; Magnetite Nanoparticles; Plaque, Amyloid; Rats; Spectrometry, Fluorescence | 2015 |